Is Krishna Institute of Medical Sciences a Good Buy After Its Q1 FY27 Results?

The Krishna Institute of Medical Sciences share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Krishna Institute of Medical Sciences is a South India-focused multi-specialty hospital chain, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 1,196 crore, up 36.1% year on year, while profit after tax came in at Rs 37 crore, down 56.0% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Krishna Institute of Medical Sciences share price from here.

This piece works through the quarter's financial highlights, the business factors behind the numbers, where the Krishna Institute of Medical Sciences share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Krishna Institute of Medical Sciences Q1 FY27 Financial Highlights

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 1,196 crore	Rs 879 crore	36.1%
EBITDA	Rs 240 crore	Rs 200 crore	20.1%
Operating Margin	20.4%	22.9%	NA
Profit Before Tax	Rs 57 crore	Rs 114 crore	-50.2%
Net Profit / (Loss)	Rs 37 crore	Rs 85 crore	-56.0%

Krishna Institute of Medical Sciences Q1 FY27 Performance Analysis

Check Krishna Institute of Medical Sciences Fundamentals on Univest Screener

Revenue growth of 36.1% for the quarter came from steady demand across the company's core business, keeping the topline trend intact for the multi-specialty hospital care sector.

Profitability is where the quarter disappointed. PAT fell 56% year on year to Rs 37 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Krishna Institute of Medical Sciences share price this quarter.

On a sequential basis, revenue moved up 10.3% sequentially from Rs 1,084 crore in the March 2026 quarter and net profit moved up 13.0% sequentially from Rs 33 crore in the prior quarter, giving a fuller picture of the trend behind the Krishna Institute of Medical Sciences share price than the year on year comparison alone.

Key Business Factors in Q1 FY27

Revenue Trend

Krishna Institute of Medical Sciences' revenue grew 36.1% year on year this quarter, taking the quarterly base to Rs 1,196 crore in a multi-specialty hospital care business that remains sensitive to demand and pricing cycles that ultimately feed through to the Krishna Institute of Medical Sciences share price.

Margin Movement

EBITDA rose 20.1% to Rs 240 crore, and operating margin moved to 20.4% from 22.9% a year earlier, a sign that cost control or pricing held up during the quarter.

Balance Sheet Position

Krishna Institute of Medical Sciences' debt-to-equity ratio stands at 1.89, a level worth monitoring given the quarter's margin trend.

Valuation Context

Krishna Institute of Medical Sciences does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Krishna Institute of Medical Sciences share price.

Dividend Details

No interim dividend was declared alongside Krishna Institute of Medical Sciences' Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Krishna Institute of Medical Sciences share price for income should watch the company's announcements around its next annual results for any dividend decision.

Krishna Institute of Medical Sciences Share Price Outlook for FY27

The key question for the rest of FY27 is whether Krishna Institute of Medical Sciences can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Krishna Institute of Medical Sciences share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.

A stabilising or improving margin trend in the next result would be the clearest signal that this quarter's profit decline was a temporary setback rather than the start of a longer slide for the Krishna Institute of Medical Sciences share price.

Krishna Institute of Medical Sciences Stock Performance

Download the Univest iOS App or Univest Android App to track Krishna Institute of Medical Sciences' live share price and get daily stock updates.

The Krishna Institute of Medical Sciences share price was trading around Rs 766 as results season played out in late August 2026, roughly 10.8% below its 52-week high of Rs 858 and well above its 52-week low of Rs 576. Promoter holding stood at 32.5% as of the June 2026 quarter.

The Krishna Institute of Medical Sciences share price has likely already absorbed some of this quarter's disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off. On profitability ratios, the company reports a return on equity of 10.74% and a book value of around Rs 89 per share, both useful reference points when judging whether the current price is reasonable.

Key Risks

Profitability Risk

The quarter's profit trend is the clearest risk here. Until Krishna Institute of Medical Sciences shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.

Leverage Risk

A debt-to-equity ratio of 1.89 means the company's earnings are more sensitive to interest rate and refinancing conditions than a lower-debt peer.

Sector and Demand Risk

As a multi-specialty hospital care business, Krishna Institute of Medical Sciences' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Krishna Institute of Medical Sciences share price well before the next result.

Conclusion

Krishna Institute of Medical Sciences' Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 56% to Rs 37 crore even as revenue rose. The Krishna Institute of Medical Sciences share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter's numbers until the margin trend turns around.

Frequently Asked Questions on Krishna Institute of Medical Sciences Q1 FY27 Results

What were Krishna Institute of Medical Sciences' Q1 FY27 results?

Ans. Krishna Institute of Medical Sciences reported Q1 FY27 revenue of Rs 1,196 crore, up 36.1% year on year, and PAT of Rs 37 crore, down 56.0% year on year.

Is Krishna Institute of Medical Sciences a good buy after its Q1 FY27 results?

Ans. Krishna Institute of Medical Sciences' profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.

What is the Krishna Institute of Medical Sciences share price today?

Ans. The Krishna Institute of Medical Sciences share price was trading around Rs 766 in late August 2026, about 10.8% below its 52-week high of Rs 858 and well above its 52-week low of Rs 576.

What is Krishna Institute of Medical Sciences' revenue and profit for Q1 FY27?

Ans. Krishna Institute of Medical Sciences reported revenue of Rs 1,196 crore and a net profit of Rs 37 crore for the quarter ended June 30, 2026.

Did Krishna Institute of Medical Sciences declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Krishna Institute of Medical Sciences' Q1 FY27 results. Investors should track the company's next annual results for any dividend announcement.

Why does Krishna Institute of Medical Sciences not have a meaningful PE ratio?

Ans. Krishna Institute of Medical Sciences does not carry a meaningful price-to-earnings ratio currently because of its recent earnings performance. Investors should use revenue and book value trends instead when assessing the stock.

What are the key risks for Krishna Institute of Medical Sciences investors right now?

Ans. The quarter's profit trend is the clearest risk here. Until Krishna Institute of Medical Sciences shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. As a multi-specialty hospital care business, Krishna Institute of Medical Sciences' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Krishna Institute of Medical Sciences share price well before the next result.

What is Krishna Institute of Medical Sciences' promoter shareholding?

Ans. Promoter holding in Krishna Institute of Medical Sciences stood at 32.5% as of the June 2026 quarter.